Journals / Turkish Journal of Veterinary and Animal Sciences / 2019 / Cilt: 43 - Sayı: 6

Neutralizing antibody titers against field strains of bovine viral diarrhea virus after vaccination with three commercial vaccines

Pages
716–723
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This studyindicated that cross-protective immune responses with the most common international BVDV vaccine strains need to be evaluated withchallenge experiments against field strains for efficient protection.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Modified killed vaccines against bovine viral diarrhea virus (BVDV) are used worldwide.
📊
Key Findings & Data:In the present study, the crossneutralizationantibody responses against field strains from seven subgenotypes of BVDV-1 and one subgenotype of BVDV-2 wereevaluated using sera obtained by three inactivated commercial vaccines.
💡
Conclusion & Impact:This studyindicated that cross-protective immune responses with the most common international BVDV vaccine strains need to be evaluated withchallenge experiments against field strains for efficient protection.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Modified killed vaccines against bovine viral diarrhea virus (BVDV) are used worldwide. In the present study, the crossneutralizationantibody responses against field strains from seven subgenotypes of BVDV-1 and one subgenotype of BVDV-2 wereevaluated using sera obtained by three inactivated commercial vaccines. One vaccine contained both BVDV-1 and BVDV-2 strains,while the others contained only BVDV-1a. Three vaccine groups, each containing five calves, were vaccinated two times with 30-day intervals. The antibody titers were evaluated by virus neutralization assay. The monovalent vaccine induced the highest antibodytiters. Significant levels of neutralizing antibody titers were maintained up to the last sampling time. Although one vaccine containedthe BVDV-2 strain, the lowest antibody titers were detected against field strains from BVDV-2, BVDV-1b, and BVDV-1r. This studyindicated that cross-protective immune responses with the most common international BVDV vaccine strains need to be evaluated withchallenge experiments against field strains for efficient protection.

🔖

Cite This Article

YEŞİLBAĞ, K., ALPAY, G. (2022). Neutralizing antibody titers against field strains of bovine viral diarrhea virus after vaccination with three commercial vaccines. Turkish Journal of Veterinary and Animal Sciences, Cilt: 43 - Sayı: 6, 716–723. https://ajindex.com/articles/615194

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Ståhl K, Alenius S. BVDV control and eradication in Europe – an update. Jpn J Vet Res 2012; 60: 31-39
  2. Reddy JR, Xue W, Rivera S, Minocha HC. Antigenic differences between a field isolate and vaccine strains of bovine viral diarrhea virus. J Clin Microbiol 1995; 33: 2159-2161
  3. Yeşilbağ K, Alpay G, Becher P. Variability and global distribution of subgenotypes of bovine viral diarrhea virus. Viruses 2017; 9: 128
  4. Xue F, Zhu YM, Li J, Zhu LC, Ren XG et al. Genotyping of bovine viral diarrhea viruses from cattle in china between 2005 and 2008. Vet Microbiol 2010; 143: 379-383
  5. Yeşilbağ K, Förster C, Bank-Wolf B, Yılmaz Z, Alkan F et al. Genetic heterogeneity of bovine viral diarrhoea virus (BVDV) isolates from Turkey: Identification of a new subgroup in BVDV-1. Vet Microbiol 2008; 130: 258-267
  6. Yeşilbağ K, Förster C, Ozyiğit MO, Alpay G, Tuncer P et al. Characterisation of bovine viral diarrhoea virus (BVDV) isolates from an outbreak with haemorrhagic enteritis and severe pneumonia. Vet Microbiol 2014; 169: 42-49
  7. Giangaspero M, Harasawa R, Weber L, Belloli A. Taxonomic and epidemiological aspect of the bovine viral diarrhoea virus 2 through the observation of the secondary structures in the 5’ genomic untranslated region. Vet Ital 2008; 44: 319-345
  8. Ridpath JF. Practical significance of heterogeneity among BVDV strains: impact of biotype and genotype on U.S. control programs. Prev Vet Med 2005; 72: 17-30
  9. Fulton RW, Ridpath JF, Confer AW, Saliki JT, Burge LJ et al. Bovine viral diarrhea virus antigenic diversity: impact on disease and vaccination programmes. Biologicals 2003; 31: 89-95
  10. Zimmer GM, Wentink GH, Bruschke C, Westenbrink FJ, Brinkhof J et al. Failure of foetal protection after vaccination against an experimental infection with bovine virus diarrhea virus. Vet Microbiol 2002; 89: 255-265
  11. Fulton RW. Impact of species and subgenotypes of bovine viral diarrhea virus on control by vaccination. Anim Health Res Rev 2015; 16: 40-54
  12. Wernike K, Michelitsch A, Aebischer A, Schaarschmidt U, Konrath A et al. The occurrence of a commercial Npro and Erns double mutant BVDV-1 live-vaccine strain in newborn calves. Viruses 2018; 10: 274
  13. Cedillio RS. Charakterisierung ruminanter Pestiviren mittels Polymerasekettenreaktion und monoklonaler Antikörper. Justus Liebig University Giessen, GER (Dissertation), 2004
  14. Beer M, Hehnen HR, Wolfmeyer A, Poll G, Kaaden OR et al. A new inactivated BVDV genotype I and II vaccine.